Capital Fund Management (CFM)’s United Therapeutics UTHR Stock Holding History

Capital Fund Management (CFM)’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,800	Closed	-$247K	–	2041
2019 Q4	$247K	Buy	+2,800	New	+$246K	﹤0.01%	1674
2019 Q3	–	Sell	-3,100	Closed	-$242K	–	1912
2019 Q2	$242K	Buy	+3,100	New	+$290K	﹤0.01%	1459
2019 Q1	–	Sell	-2,000	Closed	-$218K	–	2113
2018 Q4	$218K	Buy	+2,000	New	+$232K	﹤0.01%	1727
2018 Q2	–	Sell	-9,300	Closed	-$1.04M	–	2290
2018 Q1	$1.04M	Buy	+9,300	New	+$1.18M	0.01%	1219
2015 Q3	–	Sell	-2,400	Closed	-$417K	–	1681
2015 Q2	$417K	Buy	+2,400	New	+$432K	0.01%	1146
2013 Q4	–	Sell	-4,900	Closed	-$386K	–	1852
2013 Q3	$386K	Buy	+4,900	New	+$358K	0.01%	1261

Other funds holding UTHR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Capital Fund Management (CFM)'s UTHR Position: Q1 2026 in Review

Capital Fund Management (CFM) increased its United Therapeutics (UTHR) stake by 47% in Q1 2026, buying an estimated $7.77M and bringing the position to 48,964 shares worth $29M. The position accounts for 0.13% of the portfolio, ranked #194.

Capital Fund Management (CFM) first reported a position in UTHR in Q2 2013 and has held it in 31 quarters since. 851 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

Capital Fund Management (CFM) held 48,964 shares of United Therapeutics worth $29M as of Q1 2026.
Capital Fund Management (CFM) bought 15,605 United Therapeutics shares in Q1 2026, an estimated $7.77M.
United Therapeutics made up 0.13% of Capital Fund Management (CFM)'s portfolio in Q1 2026, its #194 holding.
Capital Fund Management (CFM) first reported a position in United Therapeutics in Q2 2013 and has held it in 31 quarters since.
851 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2026, filed 14 May 2026.